NO910403L - Fremgangsmaate for fremstilling av farmasoeytisk preparat. - Google Patents
Fremgangsmaate for fremstilling av farmasoeytisk preparat.Info
- Publication number
- NO910403L NO910403L NO91910403A NO910403A NO910403L NO 910403 L NO910403 L NO 910403L NO 91910403 A NO91910403 A NO 91910403A NO 910403 A NO910403 A NO 910403A NO 910403 L NO910403 L NO 910403L
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- pharmaceutical preparation
- layer
- preparing pharmaceutical
- active medicament
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Physical Water Treatments (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Laminated Bodies (AREA)
Priority Applications (28)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IE39089A IE62871B1 (en) | 1988-03-08 | 1989-02-07 | Compositions with enhanced penetration |
ZA891031A ZA891031B (en) | 1988-03-08 | 1989-02-09 | Compositions with enhanced penetration |
NZ228094A NZ228094A (en) | 1988-03-08 | 1989-02-22 | Transmembranally administerable compositions containing bioaffecting agent and gelling agent |
AU30258/89A AU611771B2 (en) | 1988-03-08 | 1989-02-23 | Compositions with enhanced penetration |
PH38267A PH26548A (en) | 1988-03-08 | 1989-03-01 | Compositions with enhanced penetration |
DE89104017T DE68907081T2 (de) | 1988-03-08 | 1989-03-07 | Mittel mit erhöhtem Penetrationsvermögen. |
AT89104017T ATE90571T1 (de) | 1988-03-08 | 1989-03-07 | Mittel mit erhoehtem penetrationsvermoegen. |
ES89104017T ES2056981T3 (es) | 1988-03-08 | 1989-03-07 | Composiciones dotadas de una capacidad de penetracion mejorada. |
JP5306989A JP2939264B2 (ja) | 1988-03-08 | 1989-03-07 | 浸透強化組成物 |
DK198901096A DK175621B1 (da) | 1988-03-08 | 1989-03-07 | Præparater med forbedret penetration |
EP89104017A EP0332147B1 (en) | 1988-03-08 | 1989-03-07 | Compositions with enhanced penetration |
US07/391,808 US5019395A (en) | 1988-03-08 | 1989-08-09 | Compositions with enhanced penetration |
NZ236921A NZ236921A (en) | 1988-03-08 | 1991-01-28 | Laminate for transmembranal administration of a drug |
ZA91624A ZA91624B (en) | 1991-01-28 | 1991-01-28 | Delivery device for compositions with enhanced penetration and process for preparing same |
CA002035143A CA2035143A1 (en) | 1988-03-08 | 1991-01-29 | Compositions with enhanced penetration |
IE30591A IE64308B1 (en) | 1988-03-08 | 1991-01-29 | Compositions with enhanced penetration |
AU70061/91A AU634015B2 (en) | 1988-03-08 | 1991-01-29 | Compositions with enhanced penetration |
FI910455A FI910455A (fi) | 1988-03-08 | 1991-01-30 | Komposition med foerbaettrad penetration. |
KR1019910001750A KR100191456B1 (ko) | 1988-03-08 | 1991-02-01 | 침투력이 향상된 조성물 |
NO91910403A NO910403L (no) | 1988-03-08 | 1991-02-01 | Fremgangsmaate for fremstilling av farmasoeytisk preparat. |
JP3038921A JPH04338325A (ja) | 1988-03-08 | 1991-02-12 | 増強された浸透性を有する組成物 |
PT96779A PT96779B (pt) | 1988-03-08 | 1991-02-15 | Laminado composito de duas camadas |
ES91102354T ES2064780T3 (es) | 1988-03-08 | 1991-02-19 | Composiciones con penetracion mejorada. |
DE69105480T DE69105480T2 (de) | 1988-03-08 | 1991-02-19 | Mittel mit erhöhtem Penetrationsvermögen. |
DK91102354.7T DK0499662T3 (da) | 1988-03-08 | 1991-02-19 | Præparater med forøget penetration |
AT91102354T ATE114481T1 (de) | 1988-03-08 | 1991-02-19 | Mittel mit erhöhtem penetrationsvermögen. |
EP91102354A EP0499662B1 (en) | 1988-03-08 | 1991-02-19 | Compositions with enhanced penetration |
GR950400229T GR3014988T3 (en) | 1988-03-08 | 1995-02-08 | Compositions with enhanced penetration. |
Applications Claiming Priority (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16532288A | 1988-03-08 | 1988-03-08 | |
ZA91624A ZA91624B (en) | 1991-01-28 | 1991-01-28 | Delivery device for compositions with enhanced penetration and process for preparing same |
NZ236921A NZ236921A (en) | 1988-03-08 | 1991-01-28 | Laminate for transmembranal administration of a drug |
CA002035143A CA2035143A1 (en) | 1988-03-08 | 1991-01-29 | Compositions with enhanced penetration |
AU70061/91A AU634015B2 (en) | 1988-03-08 | 1991-01-29 | Compositions with enhanced penetration |
IE30591A IE64308B1 (en) | 1988-03-08 | 1991-01-29 | Compositions with enhanced penetration |
FI910455A FI910455A (fi) | 1988-03-08 | 1991-01-30 | Komposition med foerbaettrad penetration. |
NO91910403A NO910403L (no) | 1988-03-08 | 1991-02-01 | Fremgangsmaate for fremstilling av farmasoeytisk preparat. |
KR1019910001750A KR100191456B1 (ko) | 1988-03-08 | 1991-02-01 | 침투력이 향상된 조성물 |
JP3038921A JPH04338325A (ja) | 1988-03-08 | 1991-02-12 | 増強された浸透性を有する組成物 |
PT96779A PT96779B (pt) | 1988-03-08 | 1991-02-15 | Laminado composito de duas camadas |
EP91102354A EP0499662B1 (en) | 1988-03-08 | 1991-02-19 | Compositions with enhanced penetration |
Publications (2)
Publication Number | Publication Date |
---|---|
NO910403D0 NO910403D0 (no) | 1991-02-01 |
NO910403L true NO910403L (no) | 1992-08-03 |
Family
ID=32512850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO91910403A NO910403L (no) | 1988-03-08 | 1991-02-01 | Fremgangsmaate for fremstilling av farmasoeytisk preparat. |
Country Status (16)
Country | Link |
---|---|
EP (2) | EP0332147B1 (da) |
JP (2) | JP2939264B2 (da) |
KR (1) | KR100191456B1 (da) |
AT (2) | ATE90571T1 (da) |
AU (2) | AU611771B2 (da) |
CA (1) | CA2035143A1 (da) |
DE (2) | DE68907081T2 (da) |
DK (2) | DK175621B1 (da) |
ES (2) | ES2056981T3 (da) |
FI (1) | FI910455A (da) |
GR (1) | GR3014988T3 (da) |
IE (2) | IE62871B1 (da) |
NO (1) | NO910403L (da) |
NZ (2) | NZ228094A (da) |
PH (1) | PH26548A (da) |
PT (1) | PT96779B (da) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE62871B1 (en) * | 1988-03-08 | 1995-03-08 | Warner Lambert Co | Compositions with enhanced penetration |
WO1991015176A1 (en) * | 1990-04-06 | 1991-10-17 | Pharmetrix Corporation | Device and method for enhanced administration of physostigmine |
DE4334919A1 (de) * | 1993-10-13 | 1995-04-20 | Liedtke Pharmed Gmbh | Grenzwertig wirksame Arzneiformen mit Betablockern |
CA2203566C (en) * | 1994-10-24 | 2001-10-23 | Yuko Hosokawa | Percutaneously administration preparation |
DE19533089C1 (de) * | 1995-09-07 | 1997-05-22 | Hexal Ag | Tacrin-Pflaster |
DE19533772C1 (de) * | 1995-09-12 | 1998-01-02 | Hexal Ag | Tacrin/Selegilin-Pflaster |
AUPN814496A0 (en) | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
US6923983B2 (en) | 1996-02-19 | 2005-08-02 | Acrux Dds Pty Ltd | Transdermal delivery of hormones |
US6998138B2 (en) | 1996-02-19 | 2006-02-14 | Acrux Dds Pty. Ltd. | Topical delivery of anti-alopecia agents |
US6916486B2 (en) | 1996-02-19 | 2005-07-12 | Acrux Dds Pty Ltd | Transdermal delivery of analgesics |
US6929801B2 (en) | 1996-02-19 | 2005-08-16 | Acrux Dds Pty Ltd | Transdermal delivery of antiparkinson agents |
US7094422B2 (en) | 1996-02-19 | 2006-08-22 | Acrux Dds Pty Ltd. | Topical delivery of antifungal agents |
US6916487B2 (en) | 1996-02-19 | 2005-07-12 | Acrux Dds Pty Ltd | Transdermal delivery of antiemetics |
US6646379B1 (en) | 1998-12-25 | 2003-11-11 | Matsushita Electric Industrial Co., Ltd. | Metal vapor discharge lamp having cermet lead-in with improved luminous efficiency and flux rise time |
WO2000035439A1 (en) * | 1998-12-11 | 2000-06-22 | Bakulesh Mafatlal Khamar | The process for manufacturing formulation of topical beta blockers with improved efficacy |
DE10004790B4 (de) * | 2000-02-01 | 2004-09-09 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Verabreichung von Zaleplon, Verfahren zu seiner Herstellung und seine Verwendung |
US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
FR2870125B1 (fr) * | 2004-05-12 | 2010-03-26 | Dermaconcept Jmc | Formulation du type spot-on utile en cosmetologie et en dermatologie |
PL2450041T3 (pl) | 2005-10-12 | 2019-02-28 | Unimed Pharmaceuticals, Llc | Ulepszony żel zawierający testosteron do zastosowania do leczenia hipogonadyzmu |
JP5052558B2 (ja) * | 2009-04-03 | 2012-10-17 | ロート製薬株式会社 | ゲル軟膏 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH655004A5 (fr) * | 1981-10-23 | 1986-03-27 | Oreal | Composition anhydre, stable a l'oxydation, d'un compose d'anthraline dans un alkyl-ester d'acide gras en vue du traitement des maladies de la peau. |
DE3333639A1 (de) * | 1983-09-17 | 1985-03-28 | Dynamit Nobel Ag | Zubereitung von nitroestern fuer die koronartherapie |
US4649075A (en) * | 1984-08-09 | 1987-03-10 | Leonora Jost | Transdermal and transmucosal vortexed foam devices and the method of making |
ATE77962T1 (de) * | 1985-02-25 | 1992-07-15 | Univ Rutgers | Dosierungssystem fuer transdermale absorption von arzneimittelwirkstoffen. |
US4816456A (en) * | 1986-10-01 | 1989-03-28 | Summers William K | Administration of monoamine acridines in cholinergic neuronal deficit states |
AU607172B2 (en) * | 1986-12-22 | 1991-02-28 | Cygnus, Inc. | Diffusion matrix for transdermal drug administration |
US5023084A (en) * | 1986-12-29 | 1991-06-11 | Rutgers, The State University Of New Jersey | Transdermal estrogen/progestin dosage unit, system and process |
IE62871B1 (en) * | 1988-03-08 | 1995-03-08 | Warner Lambert Co | Compositions with enhanced penetration |
-
1989
- 1989-02-07 IE IE39089A patent/IE62871B1/en not_active IP Right Cessation
- 1989-02-22 NZ NZ228094A patent/NZ228094A/xx unknown
- 1989-02-23 AU AU30258/89A patent/AU611771B2/en not_active Ceased
- 1989-03-01 PH PH38267A patent/PH26548A/en unknown
- 1989-03-07 EP EP89104017A patent/EP0332147B1/en not_active Expired - Lifetime
- 1989-03-07 DE DE89104017T patent/DE68907081T2/de not_active Expired - Fee Related
- 1989-03-07 AT AT89104017T patent/ATE90571T1/de not_active IP Right Cessation
- 1989-03-07 JP JP5306989A patent/JP2939264B2/ja not_active Expired - Fee Related
- 1989-03-07 DK DK198901096A patent/DK175621B1/da not_active IP Right Cessation
- 1989-03-07 ES ES89104017T patent/ES2056981T3/es not_active Expired - Lifetime
-
1991
- 1991-01-28 NZ NZ236921A patent/NZ236921A/en unknown
- 1991-01-29 IE IE30591A patent/IE64308B1/en not_active IP Right Cessation
- 1991-01-29 CA CA002035143A patent/CA2035143A1/en not_active Abandoned
- 1991-01-29 AU AU70061/91A patent/AU634015B2/en not_active Ceased
- 1991-01-30 FI FI910455A patent/FI910455A/fi not_active Application Discontinuation
- 1991-02-01 NO NO91910403A patent/NO910403L/no unknown
- 1991-02-01 KR KR1019910001750A patent/KR100191456B1/ko not_active IP Right Cessation
- 1991-02-12 JP JP3038921A patent/JPH04338325A/ja active Pending
- 1991-02-15 PT PT96779A patent/PT96779B/pt not_active IP Right Cessation
- 1991-02-19 DK DK91102354.7T patent/DK0499662T3/da active
- 1991-02-19 ES ES91102354T patent/ES2064780T3/es not_active Expired - Lifetime
- 1991-02-19 DE DE69105480T patent/DE69105480T2/de not_active Expired - Fee Related
- 1991-02-19 EP EP91102354A patent/EP0499662B1/en not_active Expired - Lifetime
- 1991-02-19 AT AT91102354T patent/ATE114481T1/de not_active IP Right Cessation
-
1995
- 1995-02-08 GR GR950400229T patent/GR3014988T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO910403L (no) | Fremgangsmaate for fremstilling av farmasoeytisk preparat. | |
EP0235718A3 (en) | Granule remaining in stomach | |
KR900007595A (ko) | 개선된 라미네이트 복합체 및 그 제조 방법 | |
NO912470L (no) | Fremgangsmaate til fremstilling av et komposittlag paa et underlag i et apparat som inneholder elektrolytt i fast tilstand. | |
DE3677131D1 (de) | Laminate und aus diesen hergestellte formen. | |
NO905518D0 (no) | Fremgangsmaate for fremstilling av en laminert flersjiktsfilm, samt termoplastisk polymerblanding for anvendelse deri | |
EP0413034A4 (en) | Poultice and preparation thereof | |
CA2172402A1 (en) | Volatile active substance containing plaster that may be produced without solvents | |
PT84070A (en) | Composite leg platform | |
NO902851L (no) | Fremgangsmaate for fremstilling av 5,11-dihydro-6h-dipyrido(3,2-b:2',3'-e) (1,4) diazepin-6-oner og -tioner. | |
DE3853868D1 (de) | Wärmehärtende Harzzusammensetzung und Prepreg und laminierter Schichtstoff, die diese verwenden. | |
BR8904152A (pt) | Composicao,composicao curavel,verniz de laminacao,substrato,laminado e composicao de agente de cura | |
ES2059312T3 (es) | Medicamento que puede administrarse por via nasal, procedimiento para su preparacion y su aplicacion. | |
CA2082768A1 (en) | Diagonal veneer laminate | |
EP1106221A3 (de) | Holzschiene für ein Fahrgeschäft sowie Verfahren zur Herstellung und zum Montieren einer solchen Holzschiene | |
IE842355L (en) | Invalid chair based on composite materials. | |
IT8722032A0 (it) | Composizioni farmaceutiche laminate transdermali ad effetto prolungato e procedimento per la loro preparazione. | |
NO892871D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
BR8901533A (pt) | Formulacao adesiva para substratos,estrutura laminada e processo para a preparacao de uma estrutura laminada | |
Stella et al. | Curable Rubber Composition | |
DE3860778D1 (de) | Flammhemmende harzzusammensetzung und damit hergestelltes laminat. | |
DK692387A (da) | Landingsstelmekanisme med et omloebsventilaggregat til at reducere stoeddaempningskraefterne under koersel paa jorden | |
NO884306D0 (no) | Fremgangsmaate til fremstilling av animalsk ferdigfor for pattedyr og ferdigfor fremstilt i overensstemmelse med fremgangsmaaten. | |
NO880841L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
DE3670789D1 (de) | Selbstdichtende laminate und reifen mit solchem laminat. |